- Home
- ROIV vs CVLT Comparison
ROIV vs CVLT Comparison
Compare ROIV & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | CVLT |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 5.5B |
| IPO Year | 2021 | 2006 |
Fundamental Metrics
Financial Performance| Metric | ROIV | CVLT |
|---|---|---|
| Price | $28.05 | $79.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $27.56 | ★ $147.86 |
| AVG Volume (30 Days) | ★ 4.8M | 904.1K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.24 |
| Revenue | $29,053,000.00 | ★ $995,619,000.00 |
| Revenue This Year | N/A | $20.73 |
| Revenue Next Year | $385.85 | $11.56 |
| P/E Ratio | ★ N/A | $65.23 |
| Revenue Growth | N/A | ★ 18.63 |
| 52 Week Low | $8.73 | $79.51 |
| 52 Week High | $30.33 | $200.68 |
Technical Indicators
Market Signals| Indicator | ROIV | CVLT |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 31.80 |
| Support Level | $26.94 | N/A |
| Resistance Level | N/A | $91.77 |
| Average True Range (ATR) | 1.01 | 3.20 |
| MACD | -0.21 | 0.14 |
| Stochastic Oscillator | 32.70 | 11.87 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.